Serotonin syndrome (English Wikipedia)

New, Andrea M.; Nelson, Sarah; Leung, Jonathan G. (2015-10-01). Alexander, Earnest; Susla, Gregory M. (eds.). "Psychiatric Emergencies in the Intensive Care Unit". AACN Advanced Critical Care. 26 (4): 285–293. doi:10.4037/NCI.0000000000000104. ISSN 1559-7768. PMID 26484986.

biologicalpsychiatryjournal.com

Gillman, P. Ken (2006-06-01). "A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action". Biological Psychiatry. 59 (11): 1046–1051. doi:10.1016/j.biopsych.2005.11.016. ISSN 0006-3223. PMID 16460699. S2CID 12179122.

books.google.com

Ferri, Fred F. (2016). Ferri's Clinical Advisor 2017: 5 Books in 1. Elsevier Health Sciences. pp. 1154–1155. ISBN 9780323448383.
Domino, Frank J.; Baldor, Robert A. (2013). The 5-Minute Clinical Consult 2014. Lippincott Williams & Wilkins. p. 1124. ISBN 9781451188509.
Friedman, Joseph H. (2015). Medication-Induced Movement Disorders. Cambridge University Press. p. 51. ISBN 9781107066007.

cmaj.ca

Birmes P, Coppin D, Schmitt L, Lauque D (May 2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.

doi.org

New, Andrea M.; Nelson, Sarah; Leung, Jonathan G. (2015-10-01). Alexander, Earnest; Susla, Gregory M. (eds.). "Psychiatric Emergencies in the Intensive Care Unit". AACN Advanced Critical Care. 26 (4): 285–293. doi:10.4037/NCI.0000000000000104. ISSN 1559-7768. PMID 26484986.
Boyer EW, Shannon M (March 2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Archived (PDF) from the original on 2013-06-18.
Isbister GK, Buckley NA, Whyte IM (September 2007). "Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 187 (6): 361–5. doi:10.5694/j.1326-5377.2007.tb01282.x. PMID 17874986. S2CID 13108173. Archived from the original on 2009-04-12.
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM (September 2003). "The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity". QJM. 96 (9): 635–642. doi:10.1093/qjmed/hcg109. PMID 12925718.
Ener RA, Meglathery SB, Van Decker WA, Gallagher RM (March 2003). "Serotonin syndrome and other serotonergic disorders". Pain Medicine. 4 (1): 63–74. doi:10.1046/j.1526-4637.2003.03005.x. PMID 12873279.
Isenberg D, Wong SC, Curtis JA (September 2008). "Serotonin syndrome triggered by a single dose of suboxone". American Journal of Emergency Medicine. 26 (7): 840.e3–5. doi:10.1016/j.ajem.2008.01.039. PMID 18774063.
Gnanadesigan N, Espinoza RT, Smith RL (June 2005). "The serotonin syndrome". New England Journal of Medicine. 352 (23): 2454–2456. doi:10.1056/NEJM200506093522320. PMID 15948273.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. PMID 20849327. S2CID 42588722.
Braun U, Kalbhen DA (October 1973). "Evidence for the Biogenic Formation of Amphetamine Derivatives from Components of Nutmeg". Pharmacology. 9 (5): 312–316. doi:10.1159/000136402. PMID 4737998.
Steinberg M, Morin AK (January 2007). "Mild serotonin syndrome associated with concurrent linezolid and fluoxetine". American Journal of Health-System Pharmacy. 64 (1): 59–62. doi:10.2146/ajhp060227. PMID 17189581.
Karki SD, Masood GR (2003). "Combination risperidone and SSRI-induced serotonin syndrome". Annals of Pharmacotherapy. 37 (3): 388–391. doi:10.1345/aph.1C228. PMID 12639169. S2CID 36677580.
Ramsay RR, Dunford C, Gillman PK (2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". Br J Pharmacol. 152 (6): 946–51. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Sun-Edelstein C, Tepper SJ, Shapiro RE (September 2008). "Drug-induced serotonin syndrome: a review". Expert Opinion on Drug Safety. 7 (5): 587–596. doi:10.1517/14740338.7.5.587. PMID 18759711. S2CID 71657093.
Sternbach H (June 1991). "The serotonin syndrome". American Journal of Psychiatry. 148 (6): 705–713. doi:10.1176/ajp.148.6.705. PMID 2035713. S2CID 29916415.
Gillman, P. Ken (2006-06-01). "A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action". Biological Psychiatry. 59 (11): 1046–1051. doi:10.1016/j.biopsych.2005.11.016. ISSN 0006-3223. PMID 16460699. S2CID 12179122.
Isbister GK, Downes F, Whyte IM (April 2003). "Olanzapine and serotonin toxicity". Psychiatry and Clinical Neurosciences. 57 (2): 241–42. doi:10.1046/j.1440-1819.2003.01110.x. PMID 12667176. S2CID 851495.
Gillman P (2006). "A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status". Human Psychopharmacology. 21 (2): 117–125. doi:10.1002/hup.750. PMID 16342227. S2CID 23442056.
Munhoz RP (2004). "Serotonin syndrome induced by a combination of bupropion and SSRIs". Clinical Neuropharmacology. 27 (5): 219–222. doi:10.1097/01.wnf.0000142754.46045.8c. PMID 15602102.
Thorpe EL, Pizon AF, Lynch MJ, Boyer J (June 2010). "Bupropion induced serotonin syndrome: a case report". Journal of Medical Toxicology. 6 (2): 168–171. doi:10.1007/s13181-010-0021-x. PMC 3550303. PMID 20238197.
Gillman PK (June 2010). "Bupropion, bayesian logic and serotonin toxicity". Journal of Medical Toxicology. 6 (2): 276–77. doi:10.1007/s13181-010-0084-8. PMC 3550296. PMID 20440594.
Wenzel RG, Tepper S, Korab WE, Freitag F (November 2008). "Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?". Annals of Pharmacotherapy. 42 (11): 1692–1696. doi:10.1345/aph.1L260. PMID 18957623. S2CID 24942783.
Duggal HS, Fetchko J (April 2002). "Serotonin syndrome and atypical antipsychotics". American Journal of Psychiatry. 159 (4): 672–73. doi:10.1176/appi.ajp.159.4.672-a. PMID 11925312.
Boyer and Shannon's reply to Gillman PK (June 2005). "The serotonin syndrome". New England Journal of Medicine. 352 (23): 2454–2456. doi:10.1056/NEJM200506093522320. PMID 15948272.
Laine K, Heikkinen T, Ekblad U, Kero P (July 2003). "Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations". Archives of General Psychiatry. 60 (7): 720–726. doi:10.1001/archpsyc.60.7.720. PMID 12860776.
Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ (September 2001). "Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?". Archives of Disease in Childhood. Fetal and Neonatal Edition. 85 (2): F147–48. doi:10.1136/fn.85.2.F145g. PMC 1721292. PMID 11561552.
Gill M, LoVecchio F, Selden B (April 1999). "Serotonin syndrome in a child after a single dose of fluvoxamine". Annals of Emergency Medicine. 33 (4): 457–459. doi:10.1016/S0196-0644(99)70313-6. PMID 10092727.
Isbister G, Bowe S, Dawson A, Whyte I (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J Toxicol Clin Toxicol. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Whyte IM, Dawson AH (2002). "Redefining the serotonin syndrome [abstract]". Journal of Toxicology: Clinical Toxicology. 40 (5): 668–69. doi:10.1081/CLT-120016866. S2CID 218865517.
Vuori E, Henry J, Ojanperä I, Nieminen R, Savolainen T, Wahlsten P, Jäntti M (2003). "Death following ingestion of MDMA (ecstasy) and moclobemide". Addiction. 98 (3): 365–368. doi:10.1046/j.1360-0443.2003.00292.x. PMID 12603236.
Boyer EW (July 2012). "Management of opioid analgesic overdose". The New England Journal of Medicine. 367 (2): 146–155. doi:10.1056/NEJMra1202561. PMC 3739053. PMID 22784117.
Rickli, Anna; et al. (2018). "Opioid-induced Inhibition of the Human 5-HT and Noradrenaline Transporters in Vitro: Link to Clinical Reports of Serotonin Syndrome". British Journal of Pharmacology. 175 (3): 532–543. doi:10.1111/bph.14105. PMC 5773950. PMID 29210063.
Bair MJ, Robinson RL, Katon W, Kroenke K (November 2003). "Depression and pain comorbidity: a literature review". Archives of Internal Medicine. 163 (20): 2433–2445. doi:10.1001/archinte.163.20.2433. PMC 3739053. PMID 14609780.
Takeshita J, Litzinger MH (2009). "Serotonin Syndrome Associated With Tramadol". Primary Care Companion to the Journal of Clinical Psychiatry. 11 (5): 273. doi:10.4088/PCC.08l00690. PMC 2781045. PMID 19956471.
Oates JA, Sjoerdsma A (December 1960). "Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor". Neurology. 10 (12): 1076–8. doi:10.1212/WNL.10.12.1076. PMID 13730138. S2CID 40439836.
Whyte I, Dawson A, Buckley N (2003). "Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants". QJM. 96 (5): 369–74. doi:10.1093/qjmed/hcg062. PMID 12702786.
Gillman PK (June 2004). "The spectrum concept of serotonin toxicity". Pain Med. 5 (2): 231–2. doi:10.1111/j.1526-4637.2004.04033.x. PMID 15209988.
Gillman PK (June 2006). "A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action". Biol Psychiatry. 59 (11): 1046–51. doi:10.1016/j.biopsych.2005.11.016. PMID 16460699. S2CID 12179122.
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998). "The serotonin syndrome scale: first results on validity". Eur Arch Psychiatry Clin Neurosci. 248 (2): 96–103. doi:10.1007/s004060050024. PMID 9684919. S2CID 37993326. Archived from the original on 1999-10-11.
Nisijima K, Shioda K, Iwamura T (2007). "Neuroleptic malignant syndrome and serotonin syndrome". Neurobiology of Hyperthermia. Progress in Brain Research. Vol. 162. pp. 81–104. doi:10.1016/S0079-6123(06)62006-2. ISBN 9780444519269. PMID 17645916. {{cite book}}: |journal= ignored (help)
Tormoehlen, LM; Rusyniak, DE (2018). "Neuroleptic malignant syndrome and serotonin syndrome". Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Handbook of Clinical Neurology. Vol. 157. pp. 663–675. doi:10.1016/B978-0-444-64074-1.00039-2. ISBN 9780444640741. PMID 30459031.
Isbister GK, Dawson A, Whyte IM (September 2001). "Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome?". Can J Psychiatry. 46 (7): 657–9. doi:10.1177/070674370104600718. PMID 11582830.
Prakash, Sanjay; Shah, Chetsi S.; Prakash, Anurag (2024-06-09). "Serotonin syndrome controversies: A need for consensus". World Journal of Critical Care Medicine. 13 (2): 94707. doi:10.5492/wjccm.v13.i2.94707. ISSN 2220-3141. PMC 11155509. PMID 38855279.
Scotton, William J; Hill, Lisa J; Williams, Adrian C; Barnes, Nicholas M (2019). "Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions". International Journal of Tryptophan Research. 12. SAGE Publications: 117864691987392. doi:10.1177/1178646919873925. ISSN 1178-6469. PMC 6734608. PMID 31523132.
Sporer K (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Saf. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Graudins A, Stearman A, Chan B (1998). "Treatment of the serotonin syndrome with cyproheptadine". J Emerg Med. 16 (4): 615–9. doi:10.1016/S0736-4679(98)00057-2. PMID 9696181.
Gillman PK (1999). "The serotonin syndrome and its treatment". J Psychopharmacol (Oxford). 13 (1): 100–9. doi:10.1177/026988119901300111. PMID 10221364. S2CID 17640246.
Nisijima K, Yoshino T, Yui K, Katoh S (January 2001). "Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome". Brain Res. 890 (1): 23–31. doi:10.1016/S0006-8993(00)03020-1. PMID 11164765. S2CID 29995925.
Prator B (2006). "Serotonin syndrome". J Neurosci Nurs. 38 (2): 102–5. doi:10.1097/01376517-200604000-00005. PMID 16681290.
Chechani V (February 2002). "Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy". Crit Care Med. 30 (2): 473–6. doi:10.1097/00003246-200202000-00033. PMID 11889332. S2CID 28908329.
Haddad PM (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722. S2CID 26897797.
Mason PJ, Morris VA, Balcezak TJ (July 2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine (Baltimore). 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349. S2CID 41036864.
Asch DA, Parker RM (March 1988). "The Libby Zion case. One step forward or two steps backward?". N Engl J Med. 318 (12): 771–5. doi:10.1056/NEJM198803243181209. PMID 3347226.

drugs.com

"Tramadol Hydrochloride". drugs.com. The American Society of Health-System Pharmacists. Retrieved 12 December 2020.

drugwise.org.uk

"AMT". DrugWise.org.uk. 2016-01-03. Retrieved 2019-11-18.

erowid.org

"Erowid Yohimbe Vaults: Notes on Yohimbine by William White, 1994". Erowid.org. Archived from the original on 2013-01-26. Retrieved 2013-01-28.

healthcentral.com

Taylor, Marygrace (2009-05-12). "Does the Caffeine in Your Coffee, Tea, or Soft Drinks Interfere With Antidepressants?". HealthCentral. Retrieved 2024-06-30.

legal-high-inhaltsstoffe.de

Alpha-methyltryptamine (AMT) – Critical Review Report (PDF) (Report). World Health Organisation – Expert Committee on Drug Dependence (published 2014-06-20). 20 June 2014. Retrieved 2019-11-18.

minervamedica.it

Verre M, Bossio F, Mammone A, et al. (2008). "Serotonin syndrome caused by olanzapine and clomipramine". Minerva Anestesiologica. 74 (1–2): 41–45. PMID 18004234. Archived from the original on 2009-01-08.

mja.com.au

Isbister GK, Buckley NA, Whyte IM (September 2007). "Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 187 (6): 361–5. doi:10.5694/j.1326-5377.2007.tb01282.x. PMID 17874986. S2CID 13108173. Archived from the original on 2009-04-12.

nih.gov

pubmed.ncbi.nlm.nih.gov

Volpi-Abadie J, Kaye AM, Kaye AD (2013). "Serotonin syndrome". The Ochsner Journal. 13 (4): 533–40. PMC 3865832. PMID 24358002.
New, Andrea M.; Nelson, Sarah; Leung, Jonathan G. (2015-10-01). Alexander, Earnest; Susla, Gregory M. (eds.). "Psychiatric Emergencies in the Intensive Care Unit". AACN Advanced Critical Care. 26 (4): 285–293. doi:10.4037/NCI.0000000000000104. ISSN 1559-7768. PMID 26484986.
Boyer EW, Shannon M (March 2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Archived (PDF) from the original on 2013-06-18.
Brensilver JM, Smith L, Lyttle CS (September 1998). "Impact of the Libby Zion case on graduate medical education in internal medicine". The Mount Sinai Journal of Medicine, New York. 65 (4): 296–300. PMID 9757752.
Isbister GK, Buckley NA, Whyte IM (September 2007). "Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 187 (6): 361–5. doi:10.5694/j.1326-5377.2007.tb01282.x. PMID 17874986. S2CID 13108173. Archived from the original on 2009-04-12.
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM (September 2003). "The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity". QJM. 96 (9): 635–642. doi:10.1093/qjmed/hcg109. PMID 12925718.
Ener RA, Meglathery SB, Van Decker WA, Gallagher RM (March 2003). "Serotonin syndrome and other serotonergic disorders". Pain Medicine. 4 (1): 63–74. doi:10.1046/j.1526-4637.2003.03005.x. PMID 12873279.
Isenberg D, Wong SC, Curtis JA (September 2008). "Serotonin syndrome triggered by a single dose of suboxone". American Journal of Emergency Medicine. 26 (7): 840.e3–5. doi:10.1016/j.ajem.2008.01.039. PMID 18774063.
Gnanadesigan N, Espinoza RT, Smith RL (June 2005). "The serotonin syndrome". New England Journal of Medicine. 352 (23): 2454–2456. doi:10.1056/NEJM200506093522320. PMID 15948273.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. PMID 20849327. S2CID 42588722.
Bijl D (October 2004). "The serotonin syndrome". Netherlands Journal of Medicine. 62 (9): 309–313. PMID 15635814. Mechanisms of serotonergic drugs implicated in serotonin syndrome ... Stimulation of serotonin receptors ... LSD
Braun U, Kalbhen DA (October 1973). "Evidence for the Biogenic Formation of Amphetamine Derivatives from Components of Nutmeg". Pharmacology. 9 (5): 312–316. doi:10.1159/000136402. PMID 4737998.
Birmes P, Coppin D, Schmitt L, Lauque D (May 2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.
Steinberg M, Morin AK (January 2007). "Mild serotonin syndrome associated with concurrent linezolid and fluoxetine". American Journal of Health-System Pharmacy. 64 (1): 59–62. doi:10.2146/ajhp060227. PMID 17189581.
Karki SD, Masood GR (2003). "Combination risperidone and SSRI-induced serotonin syndrome". Annals of Pharmacotherapy. 37 (3): 388–391. doi:10.1345/aph.1C228. PMID 12639169. S2CID 36677580.
Verre M, Bossio F, Mammone A, et al. (2008). "Serotonin syndrome caused by olanzapine and clomipramine". Minerva Anestesiologica. 74 (1–2): 41–45. PMID 18004234. Archived from the original on 2009-01-08.
Ramsay RR, Dunford C, Gillman PK (2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". Br J Pharmacol. 152 (6): 946–51. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Foong AL, Grindrod KA, Patel T, Kellar J (October 2018). "Demystifying serotonin syndrome (or serotonin toxicity)". Canadian Family Physician. 64 (10): 720–727. PMC 6184959. PMID 30315014.
Sun-Edelstein C, Tepper SJ, Shapiro RE (September 2008). "Drug-induced serotonin syndrome: a review". Expert Opinion on Drug Safety. 7 (5): 587–596. doi:10.1517/14740338.7.5.587. PMID 18759711. S2CID 71657093.
Sternbach H (June 1991). "The serotonin syndrome". American Journal of Psychiatry. 148 (6): 705–713. doi:10.1176/ajp.148.6.705. PMID 2035713. S2CID 29916415.
Gillman, P. Ken (2006-06-01). "A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action". Biological Psychiatry. 59 (11): 1046–1051. doi:10.1016/j.biopsych.2005.11.016. ISSN 0006-3223. PMID 16460699. S2CID 12179122.
Isbister GK, Downes F, Whyte IM (April 2003). "Olanzapine and serotonin toxicity". Psychiatry and Clinical Neurosciences. 57 (2): 241–42. doi:10.1046/j.1440-1819.2003.01110.x. PMID 12667176. S2CID 851495.
Gillman P (2006). "A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status". Human Psychopharmacology. 21 (2): 117–125. doi:10.1002/hup.750. PMID 16342227. S2CID 23442056.
Munhoz RP (2004). "Serotonin syndrome induced by a combination of bupropion and SSRIs". Clinical Neuropharmacology. 27 (5): 219–222. doi:10.1097/01.wnf.0000142754.46045.8c. PMID 15602102.
Thorpe EL, Pizon AF, Lynch MJ, Boyer J (June 2010). "Bupropion induced serotonin syndrome: a case report". Journal of Medical Toxicology. 6 (2): 168–171. doi:10.1007/s13181-010-0021-x. PMC 3550303. PMID 20238197.
Gillman PK (June 2010). "Bupropion, bayesian logic and serotonin toxicity". Journal of Medical Toxicology. 6 (2): 276–77. doi:10.1007/s13181-010-0084-8. PMC 3550296. PMID 20440594.
Evans RW (2007). "The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports". MedGenMed. 9 (3): 48. PMC 2100123. PMID 18092054.
Wenzel RG, Tepper S, Korab WE, Freitag F (November 2008). "Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?". Annals of Pharmacotherapy. 42 (11): 1692–1696. doi:10.1345/aph.1L260. PMID 18957623. S2CID 24942783.
Duggal HS, Fetchko J (April 2002). "Serotonin syndrome and atypical antipsychotics". American Journal of Psychiatry. 159 (4): 672–73. doi:10.1176/appi.ajp.159.4.672-a. PMID 11925312.
Boyer and Shannon's reply to Gillman PK (June 2005). "The serotonin syndrome". New England Journal of Medicine. 352 (23): 2454–2456. doi:10.1056/NEJM200506093522320. PMID 15948272.
Laine K, Heikkinen T, Ekblad U, Kero P (July 2003). "Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations". Archives of General Psychiatry. 60 (7): 720–726. doi:10.1001/archpsyc.60.7.720. PMID 12860776.
Mackay FJ, Dunn NR, Mann RD (November 1999). "Antidepressants and the serotonin syndrome in general practice". Br J Gen Pract. 49 (448): 871–4. PMC 1313555. PMID 10818650.
Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ (September 2001). "Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?". Archives of Disease in Childhood. Fetal and Neonatal Edition. 85 (2): F147–48. doi:10.1136/fn.85.2.F145g. PMC 1721292. PMID 11561552.
Gill M, LoVecchio F, Selden B (April 1999). "Serotonin syndrome in a child after a single dose of fluvoxamine". Annals of Emergency Medicine. 33 (4): 457–459. doi:10.1016/S0196-0644(99)70313-6. PMID 10092727.
Isbister G, Bowe S, Dawson A, Whyte I (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J Toxicol Clin Toxicol. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Vuori E, Henry J, Ojanperä I, Nieminen R, Savolainen T, Wahlsten P, Jäntti M (2003). "Death following ingestion of MDMA (ecstasy) and moclobemide". Addiction. 98 (3): 365–368. doi:10.1046/j.1360-0443.2003.00292.x. PMID 12603236.
Boyer EW (July 2012). "Management of opioid analgesic overdose". The New England Journal of Medicine. 367 (2): 146–155. doi:10.1056/NEJMra1202561. PMC 3739053. PMID 22784117.
Rickli, Anna; et al. (2018). "Opioid-induced Inhibition of the Human 5-HT and Noradrenaline Transporters in Vitro: Link to Clinical Reports of Serotonin Syndrome". British Journal of Pharmacology. 175 (3): 532–543. doi:10.1111/bph.14105. PMC 5773950. PMID 29210063.
Bair MJ, Robinson RL, Katon W, Kroenke K (November 2003). "Depression and pain comorbidity: a literature review". Archives of Internal Medicine. 163 (20): 2433–2445. doi:10.1001/archinte.163.20.2433. PMC 3739053. PMID 14609780.
Takeshita J, Litzinger MH (2009). "Serotonin Syndrome Associated With Tramadol". Primary Care Companion to the Journal of Clinical Psychiatry. 11 (5): 273. doi:10.4088/PCC.08l00690. PMC 2781045. PMID 19956471.
Oates JA, Sjoerdsma A (December 1960). "Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor". Neurology. 10 (12): 1076–8. doi:10.1212/WNL.10.12.1076. PMID 13730138. S2CID 40439836.
Whyte I, Dawson A, Buckley N (2003). "Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants". QJM. 96 (5): 369–74. doi:10.1093/qjmed/hcg062. PMID 12702786.
Gillman PK (June 2004). "The spectrum concept of serotonin toxicity". Pain Med. 5 (2): 231–2. doi:10.1111/j.1526-4637.2004.04033.x. PMID 15209988.
Gillman PK (June 2006). "A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action". Biol Psychiatry. 59 (11): 1046–51. doi:10.1016/j.biopsych.2005.11.016. PMID 16460699. S2CID 12179122.
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998). "The serotonin syndrome scale: first results on validity". Eur Arch Psychiatry Clin Neurosci. 248 (2): 96–103. doi:10.1007/s004060050024. PMID 9684919. S2CID 37993326. Archived from the original on 1999-10-11.
Fennell J, Hussain M (2005). "Serotonin syndrome: case report and current concepts". Ir Med J. 98 (5): 143–4. PMID 16010782.
Nisijima K, Shioda K, Iwamura T (2007). "Neuroleptic malignant syndrome and serotonin syndrome". Neurobiology of Hyperthermia. Progress in Brain Research. Vol. 162. pp. 81–104. doi:10.1016/S0079-6123(06)62006-2. ISBN 9780444519269. PMID 17645916. {{cite book}}: |journal= ignored (help)
Tormoehlen, LM; Rusyniak, DE (2018). "Neuroleptic malignant syndrome and serotonin syndrome". Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Handbook of Clinical Neurology. Vol. 157. pp. 663–675. doi:10.1016/B978-0-444-64074-1.00039-2. ISBN 9780444640741. PMID 30459031.
Christensen V, Glenthøj B (2001). "[Malignant neuroleptic syndrome or serotonergic syndrome]". Ugeskrift for Lægerer. 163 (3): 301–2. PMID 11219110.
Isbister GK, Dawson A, Whyte IM (September 2001). "Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome?". Can J Psychiatry. 46 (7): 657–9. doi:10.1177/070674370104600718. PMID 11582830.
Prakash, Sanjay; Shah, Chetsi S.; Prakash, Anurag (2024-06-09). "Serotonin syndrome controversies: A need for consensus". World Journal of Critical Care Medicine. 13 (2): 94707. doi:10.5492/wjccm.v13.i2.94707. ISSN 2220-3141. PMC 11155509. PMID 38855279.
Scotton, William J; Hill, Lisa J; Williams, Adrian C; Barnes, Nicholas M (2019). "Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions". International Journal of Tryptophan Research. 12. SAGE Publications: 117864691987392. doi:10.1177/1178646919873925. ISSN 1178-6469. PMC 6734608. PMID 31523132.
Sporer K (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Saf. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Frank, Christopher (2008). "Recognition and treatment of serotonin syndrome". Can Fam Physician. 54 (7): 988–92. PMC 2464814. PMID 18625822.
Graudins A, Stearman A, Chan B (1998). "Treatment of the serotonin syndrome with cyproheptadine". J Emerg Med. 16 (4): 615–9. doi:10.1016/S0736-4679(98)00057-2. PMID 9696181.
Gillman PK (1999). "The serotonin syndrome and its treatment". J Psychopharmacol (Oxford). 13 (1): 100–9. doi:10.1177/026988119901300111. PMID 10221364. S2CID 17640246.
Nisijima K, Yoshino T, Yui K, Katoh S (January 2001). "Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome". Brain Res. 890 (1): 23–31. doi:10.1016/S0006-8993(00)03020-1. PMID 11164765. S2CID 29995925.
Prator B (2006). "Serotonin syndrome". J Neurosci Nurs. 38 (2): 102–5. doi:10.1097/01376517-200604000-00005. PMID 16681290.
Jaunay E, Gaillac V, Guelfi J (2001). "[Serotonin syndrome. Which treatment and when?]". Presse Med. 30 (34): 1695–700. PMID 11760601.
Chechani V (February 2002). "Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy". Crit Care Med. 30 (2): 473–6. doi:10.1097/00003246-200202000-00033. PMID 11889332. S2CID 28908329.
Haddad PM (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722. S2CID 26897797.
Mason PJ, Morris VA, Balcezak TJ (July 2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine (Baltimore). 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349. S2CID 41036864.
Sampson E, Warner JP (November 1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.
Asch DA, Parker RM (March 1988). "The Libby Zion case. One step forward or two steps backward?". N Engl J Med. 318 (12): 771–5. doi:10.1056/NEJM198803243181209. PMID 3347226.

ncbi.nlm.nih.gov

Volpi-Abadie J, Kaye AM, Kaye AD (2013). "Serotonin syndrome". The Ochsner Journal. 13 (4): 533–40. PMC 3865832. PMID 24358002.
Birmes P, Coppin D, Schmitt L, Lauque D (May 2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.
Ramsay RR, Dunford C, Gillman PK (2007). "Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction". Br J Pharmacol. 152 (6): 946–51. doi:10.1038/sj.bjp.0707430. PMC 2078225. PMID 17721552.
Foong AL, Grindrod KA, Patel T, Kellar J (October 2018). "Demystifying serotonin syndrome (or serotonin toxicity)". Canadian Family Physician. 64 (10): 720–727. PMC 6184959. PMID 30315014.
Thorpe EL, Pizon AF, Lynch MJ, Boyer J (June 2010). "Bupropion induced serotonin syndrome: a case report". Journal of Medical Toxicology. 6 (2): 168–171. doi:10.1007/s13181-010-0021-x. PMC 3550303. PMID 20238197.
Gillman PK (June 2010). "Bupropion, bayesian logic and serotonin toxicity". Journal of Medical Toxicology. 6 (2): 276–77. doi:10.1007/s13181-010-0084-8. PMC 3550296. PMID 20440594.
Evans RW (2007). "The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports". MedGenMed. 9 (3): 48. PMC 2100123. PMID 18092054.
Mackay FJ, Dunn NR, Mann RD (November 1999). "Antidepressants and the serotonin syndrome in general practice". Br J Gen Pract. 49 (448): 871–4. PMC 1313555. PMID 10818650.
Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ (September 2001). "Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?". Archives of Disease in Childhood. Fetal and Neonatal Edition. 85 (2): F147–48. doi:10.1136/fn.85.2.F145g. PMC 1721292. PMID 11561552.
Boyer EW (July 2012). "Management of opioid analgesic overdose". The New England Journal of Medicine. 367 (2): 146–155. doi:10.1056/NEJMra1202561. PMC 3739053. PMID 22784117.
Rickli, Anna; et al. (2018). "Opioid-induced Inhibition of the Human 5-HT and Noradrenaline Transporters in Vitro: Link to Clinical Reports of Serotonin Syndrome". British Journal of Pharmacology. 175 (3): 532–543. doi:10.1111/bph.14105. PMC 5773950. PMID 29210063.
Bair MJ, Robinson RL, Katon W, Kroenke K (November 2003). "Depression and pain comorbidity: a literature review". Archives of Internal Medicine. 163 (20): 2433–2445. doi:10.1001/archinte.163.20.2433. PMC 3739053. PMID 14609780.
Takeshita J, Litzinger MH (2009). "Serotonin Syndrome Associated With Tramadol". Primary Care Companion to the Journal of Clinical Psychiatry. 11 (5): 273. doi:10.4088/PCC.08l00690. PMC 2781045. PMID 19956471.
Prakash, Sanjay; Shah, Chetsi S.; Prakash, Anurag (2024-06-09). "Serotonin syndrome controversies: A need for consensus". World Journal of Critical Care Medicine. 13 (2): 94707. doi:10.5492/wjccm.v13.i2.94707. ISSN 2220-3141. PMC 11155509. PMID 38855279.
Scotton, William J; Hill, Lisa J; Williams, Adrian C; Barnes, Nicholas M (2019). "Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions". International Journal of Tryptophan Research. 12. SAGE Publications: 117864691987392. doi:10.1177/1178646919873925. ISSN 1178-6469. PMC 6734608. PMID 31523132.
Frank, Christopher (2008). "Recognition and treatment of serotonin syndrome". Can Fam Physician. 54 (7): 988–92. PMC 2464814. PMID 18625822.
"Serotonin syndrome – PubMed Health". Ncbi.nlm.nih.gov. Archived from the original on 2013-02-01. Retrieved 2013-01-28.
Sampson E, Warner JP (November 1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.

nps.org.au

"Prescribing Practice Review 32: Managing depression in primary care" (PDF). National Prescribing Service Limited. 2005. Archived from the original (PDF) on 27 July 2011. Retrieved 16 July 2006.

nytimes.com

Brody, Jane (February 27, 2007). "A Mix of Medicines That Can Be Lethal". New York Times. Archived from the original on November 13, 2013. Retrieved 2009-02-13.

query.nytimes.com

Jan Hoffman (January 1, 1995). "Doctors' Accounts Vary In Death of Libby Zion". The New York Times. Archived from the original on August 16, 2009. Retrieved 2008-12-08.

rxlist.com

"Vyvanse (Lisdexamfetamine Dimesylate) Drug Information: Side Effects and Drug Interactions – Prescribing Information". RxList.com. Archived from the original on 2017-03-25. Retrieved 2017-03-22.
"Adderall (Amphetamine, Dextroamphetamine Mixed Salts) Drug Information: Side Effects and Drug Interactions – Prescribing Information". RxList. Archived from the original on 2017-03-23. Retrieved 2017-03-22.

semanticscholar.org

api.semanticscholar.org

Isbister GK, Buckley NA, Whyte IM (September 2007). "Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 187 (6): 361–5. doi:10.5694/j.1326-5377.2007.tb01282.x. PMID 17874986. S2CID 13108173. Archived from the original on 2009-04-12.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. PMID 20849327. S2CID 42588722.
Karki SD, Masood GR (2003). "Combination risperidone and SSRI-induced serotonin syndrome". Annals of Pharmacotherapy. 37 (3): 388–391. doi:10.1345/aph.1C228. PMID 12639169. S2CID 36677580.
Sun-Edelstein C, Tepper SJ, Shapiro RE (September 2008). "Drug-induced serotonin syndrome: a review". Expert Opinion on Drug Safety. 7 (5): 587–596. doi:10.1517/14740338.7.5.587. PMID 18759711. S2CID 71657093.
Sternbach H (June 1991). "The serotonin syndrome". American Journal of Psychiatry. 148 (6): 705–713. doi:10.1176/ajp.148.6.705. PMID 2035713. S2CID 29916415.
Gillman, P. Ken (2006-06-01). "A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action". Biological Psychiatry. 59 (11): 1046–1051. doi:10.1016/j.biopsych.2005.11.016. ISSN 0006-3223. PMID 16460699. S2CID 12179122.
Isbister GK, Downes F, Whyte IM (April 2003). "Olanzapine and serotonin toxicity". Psychiatry and Clinical Neurosciences. 57 (2): 241–42. doi:10.1046/j.1440-1819.2003.01110.x. PMID 12667176. S2CID 851495.
Gillman P (2006). "A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status". Human Psychopharmacology. 21 (2): 117–125. doi:10.1002/hup.750. PMID 16342227. S2CID 23442056.
Wenzel RG, Tepper S, Korab WE, Freitag F (November 2008). "Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?". Annals of Pharmacotherapy. 42 (11): 1692–1696. doi:10.1345/aph.1L260. PMID 18957623. S2CID 24942783.
Isbister G, Bowe S, Dawson A, Whyte I (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J Toxicol Clin Toxicol. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Whyte IM, Dawson AH (2002). "Redefining the serotonin syndrome [abstract]". Journal of Toxicology: Clinical Toxicology. 40 (5): 668–69. doi:10.1081/CLT-120016866. S2CID 218865517.
Oates JA, Sjoerdsma A (December 1960). "Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor". Neurology. 10 (12): 1076–8. doi:10.1212/WNL.10.12.1076. PMID 13730138. S2CID 40439836.
Gillman PK (June 2006). "A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action". Biol Psychiatry. 59 (11): 1046–51. doi:10.1016/j.biopsych.2005.11.016. PMID 16460699. S2CID 12179122.
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998). "The serotonin syndrome scale: first results on validity". Eur Arch Psychiatry Clin Neurosci. 248 (2): 96–103. doi:10.1007/s004060050024. PMID 9684919. S2CID 37993326. Archived from the original on 1999-10-11.
Sporer K (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Saf. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Gillman PK (1999). "The serotonin syndrome and its treatment". J Psychopharmacol (Oxford). 13 (1): 100–9. doi:10.1177/026988119901300111. PMID 10221364. S2CID 17640246.
Nisijima K, Yoshino T, Yui K, Katoh S (January 2001). "Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome". Brain Res. 890 (1): 23–31. doi:10.1016/S0006-8993(00)03020-1. PMID 11164765. S2CID 29995925.
Chechani V (February 2002). "Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy". Crit Care Med. 30 (2): 473–6. doi:10.1097/00003246-200202000-00033. PMID 11889332. S2CID 28908329.
Haddad PM (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722. S2CID 26897797.
Mason PJ, Morris VA, Balcezak TJ (July 2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine (Baltimore). 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349. S2CID 41036864.

springer.de

link.springer.de

Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998). "The serotonin syndrome scale: first results on validity". Eur Arch Psychiatry Clin Neurosci. 248 (2): 96–103. doi:10.1007/s004060050024. PMID 9684919. S2CID 37993326. Archived from the original on 1999-10-11.

ucsd.edu

toxicology.ucsd.edu

Boyer EW, Shannon M (March 2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Archived (PDF) from the original on 2013-06-18.

web.archive.org

Boyer EW, Shannon M (March 2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Archived (PDF) from the original on 2013-06-18.
Isbister GK, Buckley NA, Whyte IM (September 2007). "Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 187 (6): 361–5. doi:10.5694/j.1326-5377.2007.tb01282.x. PMID 17874986. S2CID 13108173. Archived from the original on 2009-04-12.
"Prescribing Practice Review 32: Managing depression in primary care" (PDF). National Prescribing Service Limited. 2005. Archived from the original (PDF) on 27 July 2011. Retrieved 16 July 2006.
"Vyvanse (Lisdexamfetamine Dimesylate) Drug Information: Side Effects and Drug Interactions – Prescribing Information". RxList.com. Archived from the original on 2017-03-25. Retrieved 2017-03-22.
"Adderall (Amphetamine, Dextroamphetamine Mixed Salts) Drug Information: Side Effects and Drug Interactions – Prescribing Information". RxList. Archived from the original on 2017-03-23. Retrieved 2017-03-22.
"Erowid Yohimbe Vaults: Notes on Yohimbine by William White, 1994". Erowid.org. Archived from the original on 2013-01-26. Retrieved 2013-01-28.
Verre M, Bossio F, Mammone A, et al. (2008). "Serotonin syndrome caused by olanzapine and clomipramine". Minerva Anestesiologica. 74 (1–2): 41–45. PMID 18004234. Archived from the original on 2009-01-08.
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998). "The serotonin syndrome scale: first results on validity". Eur Arch Psychiatry Clin Neurosci. 248 (2): 96–103. doi:10.1007/s004060050024. PMID 9684919. S2CID 37993326. Archived from the original on 1999-10-11.
"Serotonin syndrome – PubMed Health". Ncbi.nlm.nih.gov. Archived from the original on 2013-02-01. Retrieved 2013-01-28.
Brody, Jane (February 27, 2007). "A Mix of Medicines That Can Be Lethal". New York Times. Archived from the original on November 13, 2013. Retrieved 2009-02-13.
Jan Hoffman (January 1, 1995). "Doctors' Accounts Vary In Death of Libby Zion". The New York Times. Archived from the original on August 16, 2009. Retrieved 2008-12-08.

worldcat.org

search.worldcat.org

New, Andrea M.; Nelson, Sarah; Leung, Jonathan G. (2015-10-01). Alexander, Earnest; Susla, Gregory M. (eds.). "Psychiatric Emergencies in the Intensive Care Unit". AACN Advanced Critical Care. 26 (4): 285–293. doi:10.4037/NCI.0000000000000104. ISSN 1559-7768. PMID 26484986.
Gillman, P. Ken (2006-06-01). "A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action". Biological Psychiatry. 59 (11): 1046–1051. doi:10.1016/j.biopsych.2005.11.016. ISSN 0006-3223. PMID 16460699. S2CID 12179122.
Prakash, Sanjay; Shah, Chetsi S.; Prakash, Anurag (2024-06-09). "Serotonin syndrome controversies: A need for consensus". World Journal of Critical Care Medicine. 13 (2): 94707. doi:10.5492/wjccm.v13.i2.94707. ISSN 2220-3141. PMC 11155509. PMID 38855279.
Scotton, William J; Hill, Lisa J; Williams, Adrian C; Barnes, Nicholas M (2019). "Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions". International Journal of Tryptophan Research. 12. SAGE Publications: 117864691987392. doi:10.1177/1178646919873925. ISSN 1178-6469. PMC 6734608. PMID 31523132.

zenodo.org

Gillman PK (1999). "The serotonin syndrome and its treatment". J Psychopharmacol (Oxford). 13 (1): 100–9. doi:10.1177/026988119901300111. PMID 10221364. S2CID 17640246.